Evidence map›Paper›PMID 30229370›Full record

Trial reportJournal of anesthesia2018

The effect of anesthetic technique on µ-opioid receptor expression and immune cell infiltration in breast cancer.

Kirk J Levins, S Prendeville, S Conlon, D J Buggy

2 registry-linked trialsOpen access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of anesthesia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00418457 phase3completednot on this map

Regional Anesthesia and Breast Cancer Recurrence

TypeinterventionalSponsorThe Cleveland ClinicRan2007 to 2019Enrolled2,108ConditionsBreast NeoplasmsArmsGeneral anesthesia and opioids, Regional analgesia and propofol
NCT05742438 nacompletednot on this mapstarted 2023, after this paper: background citation

Effect of Dexmedetomidine Infusion, Lidocaine Infusion, and Intrathecal Morphine Injection on Biomarker for Perioperative Stress and Immune Response, and Cancer Progression and Metastasis in Colorectal Cancer Surgery

TypeinterventionalSponsorSamsung Medical CenterRan2023 to 2023Enrolled114ConditionsColorectal Cancer, Anesthesia, Cancer Metastatic, InflammationArmsLidocaine IV, Dexmedetomidine IV, intrathecal morphine
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Kirk J LevinsDepartment Anesthesia, Mater Misericordiae University Hospital, Dublin, Ireland. kirklevins@aim.com.
S PrendevilleDepartment Pathology, Mater Misericordiae University Hospital, Dublin, Ireland.
S ConlonDepartment Pathology, Mater Misericordiae University Hospital, Dublin, Ireland.
D J BuggyDepartment Anesthesia, Mater Misericordiae University Hospital, Dublin, Ireland.
Mater Misericordiae University Hospital · IECleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical histological studies demonstrate that the distribution of natural killer (NK) cells, other immune cells and μ-opioid receptors (MOR) within cancer tissue can predict cancer prognosis. No clinical study has evaluated whether anesthetic technique influences immune cell and MOR expression within human breast cancer.

methodsExcised preoperative biopsies and intraoperative breast cancer specimens from 20 patients randomly chosen from patients previously enrolled in an ongoing, prospective, randomized trial (NCT00418457) investigating the effect of anesthetic technique on long-term breast cancer outcome were immunohistochemically stained and microscopically examined by two independent investigators, masked to randomization, to quantify MOR and immune cell infiltration: CD56, CD57 (NK cells), CD4 (T helper cells), CD8 (cytotoxic T cells) and CD68 (macrophages). Patients had been randomized to receive either a propofol-paravertebral anesthetic with continuing analgesia (PPA, n = 10) or balanced general anesthetic with opioid analgesia (GA, n = 10).

resultsThere were no differences between the groups in staining intensity in preoperative biopsy specimens. Expression intensity values (median 25-75%) for MOR in intraoperative resected biopsy were higher in GA 8.5 (3-17) versus PPA 1 (0-10), p = 0.04. The numbers of MOR-positive cells were also higher in GA patients. Expression and absolute numbers of CD56, CD57, CD4 and CD68 were similar in resected tumor in both groups.

conclusionGeneral anesthesia with opioid analgesia increased resected tumor MOR expression compared with propofol-paravertebral anesthetic technique, but the anesthetic technique did not significantly influence the expression of immune cell markers.

Indexed as

AdultAnalgesiaAnalgesics, OpioidAnesthesia, GeneralAnesthetics, InhalationBreast NeoplasmsFemaleHumansKiller Cells, NaturalMacrophagesMiddle AgedPain ManagementPropofolProspective StudiesReceptors, Opioid, muAnalgesics, OpioidAnesthetics, InhalationPropofolReceptors, Opioid, muAnesthesiaBreast cancer metastasisCancerRegional anesthesiaµ-Opioid receptor in cancer

Identifiers

PMID30229370
PMCPMC6267716
OpenAlexW2891146738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.